#1 Clinical Trials Search in Europe

Ergocalciferol

Ergocalciferol, also known as vitamin D2, is being studied in various clinical trials to explore its potential benefits in different medical conditions. These trials aim to investigate the effects of ergocalciferol supplementation on vitamin D levels, immune function, kidney health, and other health outcomes. The research focuses on determining optimal dosing, safety, and efficacy of ergocalciferol in treating vitamin D deficiency and related health issues.

Table of Contents

What is Ergocalciferol?

Ergocalciferol, also known as Vitamin D2, is a form of vitamin D that plays a crucial role in maintaining bone health and supporting various bodily functions. It is similar in structure to steroids and is produced when the skin is exposed to sunlight[1]. Ergocalciferol is available as a supplement and is often used to treat vitamin D deficiency.

Other names for ergocalciferol include[2]:

  • Drisdol
  • Calciferol
  • Calcidol
  • Vitamin D2

Medical Uses

Ergocalciferol is primarily used to treat or prevent vitamin D deficiency. It has several important functions in the body[1]:

  • Regulating calcium and phosphorus levels: This helps maintain strong bones and teeth.
  • Supporting normal growth in children: Adequate vitamin D is essential for proper bone development.
  • Aiding in amino acid reabsorption in the kidneys: This process helps the body utilize proteins more efficiently.

Ergocalciferol is used to treat various conditions associated with vitamin D deficiency, including[3][4]:

  • Kidney stones: In some cases, vitamin D supplementation may help manage calcium levels in patients with kidney stones.
  • Chronic kidney disease: Patients with kidney problems often have low vitamin D levels and may benefit from supplementation.
  • Hypovitaminosis D: This is the medical term for vitamin D deficiency.

Dosage and Administration

The dosage of ergocalciferol can vary depending on the condition being treated and the severity of vitamin D deficiency. Some common dosing regimens observed in clinical trials include[2][3][4]:

  • 200,000 IU as a single dose
  • 50,000 IU weekly for 8 weeks
  • 40,000 IU, 60,000 IU, or 80,000 IU weekly
It’s important to note that these doses are used in clinical trials and may not be appropriate for everyone. Always follow your healthcare provider’s instructions regarding dosage and administration.

Potential Benefits

Research suggests that maintaining adequate vitamin D levels through ergocalciferol supplementation may have several potential benefits[2][5][6]:

  • Improved bone health: Vitamin D helps the body absorb calcium, which is essential for strong bones.
  • Enhanced immune function: Some studies suggest that vitamin D may help support the immune system.
  • Reduced inflammation: There is ongoing research into the potential anti-inflammatory effects of vitamin D.
  • Possible pain reduction: Some studies are investigating whether vitamin D supplementation can help reduce chronic pain, particularly after burn injuries.

Safety and Side Effects

Ergocalciferol is generally considered safe when used as directed by a healthcare provider. However, as with any medication, there can be potential side effects or risks[6][7]:

  • Changes in calcium levels: Your doctor may monitor your blood calcium levels while taking ergocalciferol.
  • Changes in phosphate levels: Phosphate levels may also be affected and monitored.
  • Potential interactions with other medications: Always inform your healthcare provider about all medications you’re taking.
It’s important to follow your doctor’s instructions carefully and report any unusual symptoms or side effects.

Ongoing Research

Scientists are continually studying ergocalciferol to better understand its effects and potential uses. Some areas of ongoing research include[5][6][8]:

  • Impact on immune function: Researchers are investigating how vitamin D affects the immune system, particularly in patients with kidney disease.
  • Pain management: Studies are exploring whether vitamin D supplementation can help reduce chronic pain, especially after injuries like burns.
  • Effects on inflammation and insulin resistance: Some research is looking at how vitamin D levels might influence inflammation and insulin sensitivity in the body.
  • Pregnancy outcomes: Studies are examining the effects of vitamin D supplementation during pregnancy on both mothers and babies.
These ongoing studies may provide more insights into the potential benefits and uses of ergocalciferol in the future.

Aspect Details
Main Uses Treatment of vitamin D deficiency, kidney diseases, chronic pain, inflammation
Dosage Forms Oral capsules or tablets, various strengths (e.g., 50,000 IU)
Common Dosing Weekly (e.g., 50,000 IU/week) or monthly doses, varying by study
Duration of Studies Ranging from several weeks to 12 months
Primary Outcomes Serum 25-hydroxyvitamin D levels, inflammatory markers, pain scores
Secondary Outcomes Calcium levels, phosphate levels, parathyroid hormone levels, immune function
Patient Populations Kidney disease patients, burn injury patients, pregnant women, healthy adults
Safety Monitoring Serum calcium, phosphate levels, adverse events tracking

FAQ

  • What is ergocalciferol? Ergocalciferol is a form of vitamin D, specifically vitamin D2. It is used to treat or prevent vitamin D deficiency and related conditions. In the body, it is converted to the active form of vitamin D, which helps regulate calcium and phosphorus levels.
  • What conditions are being studied with ergocalciferol supplementation? Clinical trials are investigating ergocalciferol's effects on various conditions, including kidney diseases, vitamin D deficiency, burn injuries, chronic pain, inflammation, and insulin resistance. Some studies also focus on its impact during pregnancy and in hemodialysis patients.
  • How is ergocalciferol administered in these trials? The administration of ergocalciferol varies across trials. Some studies use weekly doses (e.g., 50,000 IU per week), while others use monthly doses or single high-dose administrations. The dosage and frequency depend on the specific study objectives and patient population.
  • Are there any potential side effects of ergocalciferol supplementation? While ergocalciferol is generally considered safe, high doses can lead to vitamin D toxicity. Potential side effects may include elevated calcium levels in the blood and urine. Clinical trials closely monitor participants for any adverse effects, especially when using higher doses.
  • How long do the ergocalciferol clinical trials typically last? The duration of ergocalciferol trials varies widely. Some studies last for a few weeks, while others continue for several months or up to a year. The length depends on the specific research objectives, such as assessing short-term vitamin D repletion or long-term health outcomes.

Ongoing Clinical Trials on Ergocalciferol

  • Study on the Effects of Romosozumab and Bisphosphonates in Children and Adolescents with Osteogenesis Imperfecta

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria Belgium France Germany Hungary Italy +3

Glossary

  • Ergocalciferol: A form of vitamin D (vitamin D2) used to treat or prevent vitamin D deficiency. It is converted in the body to the active form of vitamin D.
  • 25-hydroxyvitamin D (25OHD): The main circulating form of vitamin D in the blood, used to measure vitamin D levels in the body.
  • Hypovitaminosis D: A condition characterized by low levels of vitamin D in the body, which can lead to various health issues.
  • Autosomal Dominant Tubulo-Interstitial Kidney Disease (ADTKD-MUC1): A rare genetic kidney disorder caused by mutations in the MUC1 gene, affecting kidney function.
  • Hypercalciuria: A condition where there is an excess amount of calcium in the urine, which can increase the risk of kidney stones.
  • Parathyroid Hormone (PTH): A hormone that regulates calcium levels in the body, often affected by vitamin D status.
  • Hemodialysis: A treatment for kidney failure that filters waste products from the blood when the kidneys can no longer perform this function.
  • Interleukin-6 (IL-6): An inflammatory marker in the body, often measured to assess inflammation levels.
  • Mucin-1: A protein involved in various cellular processes, studied in relation to kidney diseases and vitamin D metabolism.
  • Cathelicidin: An antimicrobial peptide involved in immune defense, potentially influenced by vitamin D levels.

References

  1. https://clinicaltrials.gov/study/NCT03743922
  2. https://clinicaltrials.gov/study/NCT03747523
  3. https://clinicaltrials.gov/study/NCT01295879
  4. https://clinicaltrials.gov/study/NCT03228862
  5. https://clinicaltrials.gov/study/NCT00892099
  6. https://clinicaltrials.gov/study/NCT05619289
  7. https://clinicaltrials.gov/study/NCT01312441
  8. https://clinicaltrials.gov/study/NCT02011828